newsChinese ABRAXANE® supply expected to be disrupted26 March 2020 | By Hannah Balfour (European Pharmaceutical Review)The marketing agent for China, BeiGene, announced the China National Medical Products Administration (NMPA) suspended the importation, sales and use of ABRAXANE.
newsCOVID-19 update: Eli Lilly assures security of insulin supply25 March 2020 | By Hannah Balfour (European Pharmaceutical Review)Having become aware of insulin shortages in pharmacies, the company has stated that its products are not backordered and should be available for delivery by wholesalers.
newsMHRA issues FMD over HMS Wholesale Limited products24 March 2020 | By Hannah Balfour (European Pharmaceutical Review)A Class 4 falsified medicines directive (FMD) has been issued by the MHRA because medicines may have left the legal supply chain to be reintroduced later through HMS Wholesale Limited.
newsAnti-malarial drugs donated to aid fight against COVID-1924 March 2020 | By Hannah Balfour (European Pharmaceutical Review)The producers of hydroxychloroquine have stated they will donate 130 million doses if the drug is approved as a treatment for the COVID-19 coronavirus.
newsUK bans parallel exporting of crucial medicines to help COVID-19 patients23 March 2020 | By Victoria Rees (European Pharmaceutical Review)The UK government has announced that the parallel export of certain essential medicines is banned, to preserve drugs for the treatment of coronavirus patients.
newsIndia should reduce dependence on China for APIs, says industry insider13 March 2020 | By European Pharmaceutical ReviewAccording to a report, supply disruption scares and price hikes due to COVID-19 are a 'wake-up call' for India to reduce its dependence on China for APIs.
newsEMA announces measures to manage drug shortages as result of COVID-1913 March 2020 | By Victoria Rees (European Pharmaceutical Review)An EU Executive Steering Group will discuss how to address the impact of medicine shortages caused due to COVID-19, says the EMA.
newsDistributing HIV drugs using mobile vans increases viral suppression, finds study12 March 2020 | By Victoria Rees (European Pharmaceutical Review)Researchers have shown that using mobile vans to deliver and dispense HIV drugs in South Africa and Uganda helps to combat the disease.
newsMHRA issues Medicine Defect Information about Aripiprazole12 March 2020 | By Hannah Balfour (European Pharmaceutical Review)The regulatory body has issued guidance based on a complaint that stated a precipitate formed in Aripiprazole 1mg/ml oral solution.
newsFDA announces changes that will soon affect compounders9 March 2020 | By Rachael Harper (European Pharmaceutical Review)A change to the law will soon be impacting compounding of certain products beginning on 23 March 2020 the US Food and Drug Administration (FDA) has announced.
articleRe-shaping pharmaceutical transport: global air cargo trends6 March 2020 | By Dominic Hyde (Crēdo on Demand at Peli BioThermal)As environmental consciousness increases, the future of pharmaceutical transport looks uncertain. Dominic Hyde discusses the impacts of these developments on air cargo and freight.
news3.5 million unlicensed erection pills seized in the UK in 20196 March 2020 | By Victoria Rees (European Pharmaceutical Review)The UK MHRA has announced that the approximately 3.5 million unlicensed erection pills seized last year are worth more than £10 million.
newsCMA levels over £3.4m in fines for competition law breaches5 March 2020 | By Hannah Balfour (European Pharmaceutical Review)The UK’s Competition and Markets Authority (CMA) has fined four companies in because of anti-competitive practices in the supply of nortriptyline.
newsIndia to restrict 10 percent of medicine exports due to coronavirus4 March 2020 | By Victoria Rees (European Pharmaceutical Review)According to reports, the Indian government has said that 26 active pharmaceutical ingredients and medicines will be under export restrictions due to the impact of COVID-19.
newsImport restrictions for cannabis-based medicines in UK updated3 March 2020 | By Victoria Rees (European Pharmaceutical Review)The UK government has changed the restrictions on importing cannabis-based medicine products into the country, allowing wholesalers to bring in larger quantities.
